Immune-based combinations for advanced hepatocellular carcinoma: shaping the direction of first-line therapy

A Rizzo, AD Ricci, G Brandi - Future Oncology, 2021 - Taylor & Francis
According to the 2020 European Society for Medical Oncology (ESMO) guidelines, three
different therapeutic options are currently available as first-line treatment for patients with …
被引用次数：71 相关文章

[引用][C] Immune-based combinations for advanced hepatocellular carcinoma: shaping the direction of first-line therapy.

A Rizzo, AD Ricci, G Brandi - Future Oncology (London, England), 2021 - europepmc.org
Immune-based combinations for advanced hepatocellular carcinoma: shaping the direction of
first-line therapy. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …

[引用][C] Immune-based combinations for advanced hepatocellular carcinoma: Shaping the direction of first-line therapy

A Rizzo, AD Ricci, G Brandi - FUTURE ONCOLOGY, 2021 - cris.unibo.it
Immune-based combinations for advanced hepatocellular carcinoma: Shaping the direction of
first-line therapy IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT …

[引用][C] Immune-based combinations for advanced hepatocellular carcinoma: shaping the direction of first-line therapy

A Rizzo, AD Ricci, G Brandi - Future oncology (London …, 2021 - pubmed.ncbi.nlm.nih.gov
Immune-based combinations for advanced hepatocellular carcinoma: shaping the direction
of first-line therapy Immune-based combinations for advanced hepatocellular carcinoma …